Sep 29, 2023 / 12:30PM GMT
Operator
Greetings and welcome to the Capricor Therapeutics HOPE-3 Program Update call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, AJ Bergmann. Thank you, AJ, you may begin.
AJ Bergmann - Capricor Therapeutics, Inc. - CFO
Thank you and good morning, everyone. Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation. These statements may include statements regarding, among other things, the efficacy, safety, and intended utilization of our product candidates, our future R&D plans, including our anticipated conduct and timing of preclinical and clinical studies, our plans to present or report additional data, our plans regarding regulatory filings, potential regulatory developments involving our product candidates, manufacturing capabilities, potential milestone payments, and/or possible uses of existing cash and investment resources.
These forward-looking statements are based on current information, assumptions, and
Capricor Therapeutics Inc Phase 3 Hope 3 Program Update Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot